{"nct_id":"NCT06691113","title":"A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal Polyps","status":"RECRUITING","status_verified_date":"2025-06","start_date":"2024-12-16","start_date_type":"ACTUAL","primary_completion_date":"2026-08-07","primary_completion_date_type":"ESTIMATED","completion_date":"2027-02-09","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["SNY"]}